Dr. Justin Reinhardt Howard, MD

Dr. Howard practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Howard's NPI, 1134360704, was assigned on March 11, 2009. Dr. Howard holds Minnesota license 53350.

Dr. Howard's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Howard's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Howard is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Howard to 2 more hospitals, 6 medical groups, 5 group practices and clinics and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Howard practices, 10 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Howard's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Howard is licensed in Minnesota.

CMS data shows 195 Medicare services from Dr. Howard across 9 procedure codes in 2024, for 162 Medicare patients. Medicare paid $16,324 for them.

CMS counts 162 Medicare patients who saw Dr. Howard in 2024. The largest group is 65 to 74, with 69 patients. 71% of them have high blood pressure, and 65% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Howard's median patient age at 52, with 51% women.

In 2024, Dr. Howard wrote 645 Medicare Part D claims for 165 patients. 72% of them were for generic drugs. CMS names the drug for 471 of them, across 17 drugs with 11 or more claims each, at $997,372 in total drug cost. In 2023, CMS named 500 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Howard for performance year 2024, reported as part of a group. Dr. Howard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Howard as offering telehealth. CMS counts 65 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Howard, more than 68% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Howard, published from 2016 to 2023. The most frequent topics are Amphiregulin, Graft vs Host Disease and Hematopoietic Stem Cell Transplantation. Dr. Howard's most frequent co-authors are Bruce Robert Blazar, MD, Alexander Khoruts, MD and Margaret L. MacMillan, MD.

CMS Open Payments shows 118 general payments to Dr. Howard from 3 drug and device companies from 2016 to 2022. Speaker and faculty fees make up the largest share, 77% of the total. Abbvie Inc. paid the most, $89,986.